SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BREVEGLIERI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.901
AS - Asia 6.291
EU - Europa 4.134
SA - Sud America 1.004
AF - Africa 157
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 21.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.663
SG - Singapore 2.224
CN - Cina 1.846
IT - Italia 927
PL - Polonia 863
BR - Brasile 806
VN - Vietnam 673
DE - Germania 521
HK - Hong Kong 484
UA - Ucraina 441
GB - Regno Unito 329
TR - Turchia 268
FR - Francia 234
FI - Finlandia 214
SE - Svezia 195
JP - Giappone 160
RU - Federazione Russa 137
IN - India 135
CA - Canada 116
ID - Indonesia 102
BD - Bangladesh 92
MX - Messico 83
NL - Olanda 73
AR - Argentina 70
ZA - Sudafrica 52
IQ - Iraq 37
BE - Belgio 35
IR - Iran 35
PK - Pakistan 35
ES - Italia 34
EC - Ecuador 31
CO - Colombia 28
VE - Venezuela 27
UZ - Uzbekistan 25
MA - Marocco 23
KR - Corea 21
LT - Lituania 20
CZ - Repubblica Ceca 19
AU - Australia 18
MY - Malesia 18
PH - Filippine 18
TN - Tunisia 17
KE - Kenya 15
CH - Svizzera 14
EG - Egitto 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
PY - Paraguay 11
AT - Austria 9
AZ - Azerbaigian 9
DZ - Algeria 9
ET - Etiopia 9
PE - Perù 9
PT - Portogallo 9
RO - Romania 9
TW - Taiwan 9
NP - Nepal 8
IE - Irlanda 7
JO - Giordania 7
BG - Bulgaria 6
GR - Grecia 6
JM - Giamaica 6
KZ - Kazakistan 6
LB - Libano 6
PA - Panama 6
TH - Thailandia 6
BH - Bahrain 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
UY - Uruguay 5
GE - Georgia 4
IL - Israele 4
PS - Palestinian Territory 4
RS - Serbia 4
YE - Yemen 4
EE - Estonia 3
HN - Honduras 3
KW - Kuwait 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
LY - Libia 2
ML - Mali 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 21.481
Salva come PNG Salva come JPEG
Città #
Singapore 1.400
Ashburn 1.166
Warsaw 849
San Jose 733
Woodbridge 698
Beijing 693
Fairfield 558
Chandler 557
Houston 497
Ann Arbor 492
Jacksonville 486
Hong Kong 470
Santa Clara 421
Ferrara 287
Wilmington 274
Seattle 242
Ho Chi Minh City 226
Dallas 222
New York 203
Nanjing 184
Cambridge 167
Hanoi 166
Los Angeles 157
Tokyo 149
Izmir 146
Bologna 120
Princeton 116
Munich 109
Lauterbourg 102
Boardman 89
Milan 88
Addison 84
Council Bluffs 82
Shanghai 79
Jakarta 68
Helsinki 65
Orem 65
Shenyang 58
Bremen 55
San Diego 54
São Paulo 53
Mexico City 50
Redwood City 48
Nanchang 46
Brooklyn 43
London 42
Turku 42
Chennai 40
Montreal 38
Da Nang 36
Falls Church 36
Hebei 35
Rio de Janeiro 35
Denver 34
Frankfurt am Main 33
Hefei 33
Haiphong 32
Moscow 32
Stockholm 32
Toronto 32
Dearborn 31
Guangzhou 31
Brussels 30
Hangzhou 30
Johannesburg 29
Zhengzhou 29
Changsha 28
Buffalo 27
Manchester 27
Tianjin 27
Auburn Hills 24
Chicago 24
Rome 24
San Francisco 24
Jiaxing 23
Poplar 22
Tashkent 22
The Dalles 22
Mountain View 21
Verona 21
Brasília 20
Curitiba 20
Atlanta 19
Dong Ket 19
Guayaquil 19
Nuremberg 17
Phoenix 17
Amsterdam 16
Columbus 16
Norwalk 16
Baghdad 15
Jinan 15
Ningbo 15
Belo Horizonte 14
Boston 14
Mumbai 14
Orange 14
Ankara 13
Brno 13
Ferrara di Monte Baldo 13
Totale 14.284
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 416
A validated cellular biobank for β-thalassemia 415
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 378
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 375
A validated THALAMOSS cellular biobank for β-thalassemia 334
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 305
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 298
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 293
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 274
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 270
SPR-based non-invasive prenatal testing for fetal sex determination 257
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 251
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 243
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 241
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 240
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 230
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 229
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 226
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 225
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 222
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 221
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 220
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 220
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 216
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 214
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 213
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 213
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 204
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 201
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 194
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 194
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 190
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 190
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 189
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 188
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 187
Cellular biosensors for the identification of fetal hemoglobin inducers 186
Alteration of microRNA biological activity with peptide nucleic acid 186
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 186
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 186
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 185
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 185
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 185
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 183
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 182
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 177
Development and molecular characterization of transgenic mice for beta-thalassemia 175
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 175
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 173
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 170
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 166
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 162
Gene therapy combined with HbF induction in beta-thalassemia 161
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 158
Gene therapy and fetal hemoglobin induction 155
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 153
Targeting the miR-221/miR-222 cluster in cancer therapy 152
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR 152
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 150
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 148
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 148
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 147
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 147
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 146
Evidences for miRNA regulation of BCL11A gene expression 146
IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo 145
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of β°39 thalassemia mutation 144
Non-invasive Prenatal Testing Using Fetal DNA 143
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 141
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 140
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 138
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 136
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 132
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 132
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 131
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 131
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 131
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 130
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 129
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 129
Detection of disorders in unamplified human genomic DNA 128
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 127
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 126
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 126
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 126
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 123
PNA-mediated alteration of mRNA splicing 120
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 120
Induction of high levels of apoptosis of temozolomide-resistant T98G glioma cells by co-administration of peptide nucleic acids targeting miR-221 and miR-222 119
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 118
SPR-based identification of microRNAs 117
null 117
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 116
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 115
Production of a cellular model for the screening of inducers of fetal haemoglobin 114
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 114
Peptide nucleic acids targeting miR-221 in human gliomas: uptake and modulation of miR-221 biological functions 110
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 110
Set up of a NK cell-sensitive tumour model in C57BL/6 mice 110
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 110
Totale 18.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.702
Totale 92.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 0 154
2021/20221.223 139 103 33 40 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024808 50 107 35 31 64 156 82 42 11 16 52 162
2024/20252.965 80 70 230 154 305 246 127 144 511 327 391 380
2025/20268.343 818 318 670 1.012 1.252 562 1.020 534 789 970 370 28
Totale 21.804